GSK Share Price | GSK Shares - Investing.com UK


GSK	London	GBP	Real-time
GSKl	BATS Europe	GBP	Delayed
GSK	NYSE	USD	Real-time
GLAXF	OTC Markets	USD	Delayed
GSKN	Mexico	MXN	Delayed
GS70y	Frankfurt	EUR	Delayed
GS71	Frankfurt	EUR	Delayed
GS71	TradeGate	EUR	Delayed
GS71	Xetra	EUR	Delayed
GSK	Buenos Aires	ARS	Delayed

Symbol

Exchange

Currency

GSK

London

GBP

GSKl

BATS Europe

GBP

GSK

NYSE

USD

GLAXF

OTC Markets

USD

GSKN

Mexico

MXN

GS70y

Frankfurt

EUR

GS71

Frankfurt

EUR

GS71

TradeGate

EUR

GS71

Xetra

EUR

GSK

Buenos Aires

ARS

GSK plc News

GSK's RSV vaccine gets approval in Japan
- BySharecast
- •25 Sept 2023
Sharecast - The FTSE 100 pharmaceutical giant said it was the first approval of an RSV vaccine for older adults in Japan. It said RSV, a prevalent and contagious respiratory virus,...
FTSE 100 Live: Stocks lower with weak start expected on Wall Street
- ByProactive Investors
- •25 Sept 2023
Proactive Investors - FTSE 100 down 44 points at 7,640 Entain (LON:ENT) slips after warning of soft online gaming revenue Aviva (LON:AV) swoops for AIG (NYSE:AIG)'s UK protection...
Glaxosmithkline receives Investment Bank Analyst Rating Update
- ByInvesting.com
- •26 Sept 2023

GSK plc Analysis

The Bullish Case For GlaxoSmithKline At Current Levels
- ByHaris Anwar
- •04 Oct 2022
- 3
U.K.’s pharmaceutical stocks offer a buying opportunity in the current economic upheaval, given their defensive nature and the vast global footprint GSK has become a leaner...
Very Slow Start For FTSE As Cable Nears Best Price For Over 3 Years
- ByConnor Campbell
- •25 May 2021
A better than forecast, but still 2nd highest ever, UK borrowing figure for April failed to move the needle for the FTSE on Tuesday. The UK index was unchanged after the bell, flat...
How Much Did The US Grow By In Q1?
- ByConnor Campbell
- •25 Apr 2021
The US is packing a lot into the final week of April, including a Fed meeting, some key Q1 data, and a stacked earnings calendar. US There are a few major events this week,...

GSK plc Company Profile

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Industry

Pharmaceuticals

Sector

Healthcare

Employees

69400

Market

United Kingdom

Name	Last	Chg. %	Vol.
Glencore	469.90	+1.93%	36.88M
BP	531.40	-1.79%	29.76M
HSBC	644.90	0.00%	19.38M
Shell	2,606.00	-2.05%	9.05M
Unilever	4,062.00	+0.68%	3.75M
Rio Tinto PLC	5,174.00	-0.23%	2.16M
AstraZeneca	11,102.00	+0.87%	1.59M

Name

Last

Chg. %

Vol.

Glencore

469.90

+1.93%

36.88M

531.40

-1.79%

29.76M

HSBC

644.90

0.00%

19.38M

Shell

2,606.00

-2.05%

9.05M

Unilever

4,062.00

+0.68%

3.75M

Rio Tinto PLC

5,174.00

-0.23%

2.16M

AstraZeneca

11,102.00

+0.87%

1.59M

Name	Last	Chg. %	Vol.
Frontline	196.90	+73.79%	22.04K
Inland ZDP Prf	46.90	+56.33%	5.47K
Clean Invest Africa	0.22	+50.00%	909.44K
Saipem	1.45	+33.46%	4.12M
Oxford Biodynamics	37.00	+29.82%	6.41M
Future	889.00	+24.42%	1.34M
Insig Ai	22.50	+21.62%	290.73K

Name

Last

Chg. %

Vol.

Frontline

196.90

+73.79%

22.04K

Inland ZDP Prf

46.90

+56.33%

5.47K

Clean Invest Africa

0.22

+50.00%

909.44K

Saipem

1.45

+33.46%

4.12M

Oxford Biodynamics

37.00

+29.82%

6.41M

Future

889.00

+24.42%

1.34M

Insig Ai

22.50

+21.62%

290.73K

Name	Last	Chg. %	Vol.
BioGaia B	101.20	-80.37%	1.05K
H Lundbeck B	38.16	-78.03%	25.79K
Inland	2.00	-76.47%	99.84K
Atlas Copco B	128.35	-66.03%	22.89K
Tomra Systems	122.70	-64.72%	55.30K
Bidstack	0.29	-53.60%	109.40M
Electrolux B	113.40	-43.85%	45.83K

Name

Last

Chg. %

Vol.

BioGaia B

101.20

-80.37%

1.05K

H Lundbeck B

38.16

-78.03%

25.79K

Inland

2.00

-76.47%

99.84K

Atlas Copco B

128.35

-66.03%

22.89K

Tomra Systems

122.70

-64.72%

55.30K

Bidstack

0.29

-53.60%

109.40M

Electrolux B

113.40

-43.85%

45.83K

Name	Last	Chg. %	Vol.
Carnival	997.60	-4.86%	1.76M
Glencore	469.90	+1.93%	36.88M
Oxford Biodynamics	37.00	+29.82%	6.41M
Lloyds Banking	44.37	+0.25%	85.10M
Vast Resources	0.26	-14.75%	169.64M

Name

Last

Chg. %

Vol.

Carnival

997.60

-4.86%

1.76M

Glencore

469.90

+1.93%

36.88M

Oxford Biodynamics

37.00

+29.82%

6.41M

Lloyds Banking

44.37

+0.25%

85.10M

Vast Resources

0.26

-14.75%

169.64M

All export earners today are going south
0
Lovely little boost from the Zantec case today. Let's hope the shares kick onwards from here
0
ITH stock
0
Bought back all the gsk that I sold back in May. It's a no brainer at this price
0
Show previous replies (2)
- You are right. Also the price has been range bound for a decade and we are now near to the lower bound. I've heard similar comments to you nearly ever year when it's price is underperforming
  0
- I wish the institutional shareholders would wake up and do something about the management team. Surely with such an abysmal performance over so long GSK must be a takeover target?
  0
- I'm only interested in swing trading this counter. If the price doesn't move I'll just collect dividends while waiting for it to bounce. The spinoff of Haleon is a good move as in this day and age companies need to be pure play to get ahead of competition. Consumer healthcare business was a distraction to their management.
  0
new management required
0
Bloodbath coming
3
- Hi John, it will be worsth ?
  0
- When will this carnage start, exacty (02/11/22)
  0
Should have taken the Unilever offer...
0
- It was madness not to.
  0
Demerger yet another damp squib in a long line of failures by Walmsley. She is unprecedented in her ability to talk the talk but to not walk the walk!
2
This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
2
Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
4

Popular Searches

Please try another search

GSK plc (GSK)

InvestingPro

People Also Watch

GSK plc News

GSK plc Analysis

GSK plc Company Profile

Income Statement

Trending Stocks